Clinical Trials Insight: 700010028
Phase of Trial: Phase III
Latest Information Update: 22 Jul 2008
At a glance
- Drugs Mifamurtide (Primary) ; Cisplatin; Doxorubicin; Ifosfamide; Methotrexate
- Indications Osteosarcoma
- Focus Registrational; Therapeutic Use
- Sponsors IDM Pharma
- 22 Jul 2008 Results for 91 patients with metastatic disease reported at ASCO 2008.
- 01 Jul 2008 CHMP has requested additional data analyses on the phase III L-MTP-PE trial before it will offer an opinion on the MAA application. IDM expect an opinion in the third quater of 2008.
- 02 Jun 2008 Results of a subgroup analysis presented at the Annual Meeting of the American Society of Clinical Oncology 2008 and an IDM Pharma media release (9089573).